12/18/2025 02:41
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector

Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/...

12/18/2025 02:44
KIOXIA SSDs Achieve Compatibility with Microchip’s Adaptec® SmartRAID 4300 Series RAID Storage Accelerator

Kioxia Corporation today announced that its 2.5-inch KIOXIA CM7 Series Enterprise PCIe® 5.0 NVMe™ 2.0, KIOXIA CD8P Series Data Center PCIe 5.0 NVMe 2.0 and KIOXIA CD8 Series Data Center PCIe 4.0 NVMe 1.4 SSDs have been successfully tested for compatibility and interoperability with the Adaptec® SmartRAID 4300 Series RAID storage accelerator card from Microchip Technology Inc. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2025121746108...